Register for updates

 
 

Medicine & Health
RSS Feed
TAU Research Reveals How Melanoma Spreads to Other Organs in the Body
Monday, August 22, 2016 11:00:00 AM

Findings may lead to a cure for the deadly disease

In a landmark discovery, researchers at Tel Aviv University have unraveled the metastatic mechanism of melanoma, the most aggressive of all skin cancers.

According to a paper published today in the journal Nature Cell Biology, the scientists discovered that before spreading to other organs, a melanoma tumor sends out tiny vesicles containing molecules of microRNA. These induce morphological changes in the dermis in preparation for receiving and transporting the cancer cells. The researchers also found chemical substances that can stop the process and are therefore promising drug candidates.

"The threat of melanoma is not in the initial tumor that appears on the skin, but rather in its metastasis — in the tumor cells sent off to colonize in vital organs like the brain, lungs, liver and bones," said research leader Dr. Carmit Levy of the Department of Human Molecular Genetics and Biochemistry at TAU's Sackler School of Medicine. "We have discovered how the cancer spreads to distant organs and found ways to stop the process before the metastatic stage."

The TAU group worked in close collaboration with Prof. Jörg D. Hoheisel and Laureen Sander at the German Cancer Research Center (DKFZ) in Heidelberg, Dr. Shoshi Greenberger at the Sheba Medical Center at Tel HaShomer, Israel and Dr. Ronen Brenner at the Wolfson Medical Center in Holon, Israel. Lab research was led by Dr. Shani Dror of Dr. Levy's research group.

Morphological changes in the dermis

Melanoma, the most aggressive and lethal type of skin cancer, causes the death of one person every 52 minutes according to data from the Skin Cancer Foundation, and the number of diagnosed cases has been on the rise for the past three decades. Despite a range of therapies developed over the years, there is still no full remedy for this life-threatening disease. The new study proposes novel and effective methods for diagnosing and preventing this most deadly of skin cancers.

The researchers began by examining pathology samples taken from melanoma patients. "We looked at samples of early melanoma, before the invasive stage," Dr. Levy said. "To our surprise we found changes in the morphology of the dermis — the inner layer of the skin — that had never before been reported. Our next task was to find out what these changes were, and how they related to melanoma."

In the ensuing study, the group was able to discover and block a central mechanism in the metastasis of melanoma.

According to Dr. Levy, scientists have known for years that melanoma forms in the outer layer of the skin, the epidermis. At this early stage, the cancer is unable to send off colonizing cancer cells because it has no access to blood vessels — the highways that carry the cells to other parts of the body. With no blood vessels present in the epidermis, the tumor first needs to contact the abundant blood vessels running through the dermis. But how was the connection made?

"We found that even before the cancer itself invades the dermis, it sends out tiny vesicles containing molecules of microRNA," Dr. Levy said. "These induce the morphological changes in the dermis in preparation for receiving and transporting the cancer cells. It then became clear to us that by blocking the vesicles, we might be able to stop the disease altogether."

Transforming melanoma into a nonthreatening illness

Having discovered the mechanism, the researchers proceeded to look for substances that could intervene and block the process in its earliest stages. They found two such chemicals: one (SB202190) inhibits the delivery of the vesicles from the melanoma tumor to the dermis; and the other (U0126) prevents the morphological changes in the dermis even after the arrival of the vesicles. Both substances were tested successfully in the lab, and may serve as promising candidates for future drugs. In addition, the changes in the dermis, as well as the vesicles themselves, can be used as powerful indicators for early diagnosis of melanoma.

"Our study is an important step on the road to a full remedy for the deadliest skin cancer," said Dr. Levy. "We hope that our findings will help turn melanoma into a nonthreatening, easily curable disease."




Latest News

TAU Scientists Make Paralyzed Rats Walk Again

Using stem cell-based biomedical engineering to rehabilitate a severed spinal cord, TAU and Technion scientists restore control of their legs.

Byzantine Mosaic Unearthed at Ashdod-Yam in Israel

Greek inscription is earliest known use of the Georgian calendar, TAU researchers say.

Hyperbaric Oxygen Therapy May Alleviate Symptoms of Alzheimer's Disease

Treatment has potential to correct behavioral and physical deficits associated with the disease, TAU researchers say.

Skipping Breakfast Disrupts "Clock Genes" that Regulate Body Weight and Glucose

Consuming breakfast normalizes the expression of genes that improve insulin and glucose responses all day long, TAU researchers say.

Dual Virtual Reality/Treadmill Exercises Promote Brain Plasticity in Parkinson's Patients

Therapy effective even in later stages of the disease, TAU researchers say.

AFTAU to Celebrate the Steve Tisch School of Film & Television at Annual Gala Dinner

Philanthropist and producer Steve Tisch to be honored; prominent industry leaders to serve as vice chairs.

Children's Exposure to Secondhand Smoke May Be Vastly Underestimated by Parents

Smoking parents misperceive where and when their kids are exposed to cigarette smoke, TAU researchers say.

Your Stress and Mine

TAU study assesses how we perceive other people's stress levels in the workplace.

Consumption of Nicotine in Adolescence May Lead to Increased Alcohol Intake Later in Life

Nicotine "memories" from adolescence may lead to alcoholism years later, TAU researchers say.

When You're Tired, Your Brain Cells Actually Slow Down

Sleep rhythms can disrupt normal activity in specific regions of the brain, say TAU, UCLA and UW researchers.

contentSecondary
c

© 2017 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University